Justia Antitrust & Trade Regulation Opinion Summaries

by
This consolidated opinion, delivered by the United States Court of Appeals for the Fourth Circuit, pertains to the appeals of defendants Richard Tipton and James Roane, Jr. Both were convicted in 1993 and sentenced to death and multiple years in prison for involvement in a drug-related enterprise that also included firearms, murders, and other racketeering activity. They have consistently sought post-conviction relief, and in light of recent Supreme Court decisions, they contested their sentences related to their firearm-related 18 U.S.C. § 924(c) convictions in 1993.The court affirmed the district court's decisions, rejecting the defendants' challenges to their § 924(c) sentences. The court concluded that Violent Crimes in Aid of Racketeering Activity (VICAR) murder constitutes a "crime of violence" under § 924(c). The defendants failed to demonstrate that there was more than a reasonable possibility that the jury did not rely on the valid VICAR murder predicate for any of their § 924(c) convictions. Therefore, the validity of any other alleged § 924(c) predicate did not need to be decided. The court held that the defendants' § 924(c) convictions and sentences were legally sound. View "United States v. Tipton" on Justia Law

by
The case was heard in the United States Court of Appeals for the Second Circuit between Regeneron Pharmaceuticals, Inc., the plaintiff-appellant, against Novartis Pharma AG and associates, the defendants-appellees. Regeneron appealed the judgment from the district court which dismissed its claims of antitrust violations and tortious interference with contract under the Federal Rules of Civil Procedure 12(b)(6).Regeneron and Novartis both manufacture medications to treat overproduction of a specific protein. The crux of the dispute was whether the medications, which come in vials and prefilled syringes (PFSs), compete in the same or in different product markets. Regeneron claimed that Novartis and its co-defendant Vetter Pharma International GmbH concealed their collaboration to produce a PFS version of Novartis’s drug, thereby delaying the launch of Regeneron's own PFS version and allowing Novartis to increase its market share.The district court had granted the motion to dismiss, reasoning that Regeneron failed to plausibly allege that the relevant antitrust market was limited to PFSs. The court also dismissed Regeneron’s tortious interference claim as untimely.On appeal, the United States Court of Appeals for the Second Circuit reversed the lower court's decision. The appellate court held that Regeneron had provided a plausible explanation that the market for PFSs was distinct from that for vials. It also held that Regeneron adequately pleaded that Novartis was equitably estopped from asserting a statute of limitations defense to the tortious interference claim. The case was remanded for further proceedings consistent with the appellate court’s opinion. View "Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG" on Justia Law

by
The case in question is a petition for a writ of mandamus filed by Abbott Laboratories, Abbvie Inc., Abbvie Products LLC, Unimed Pharmaceuticals LLC, and Besins Healthcare, Inc. These petitioners were involved in a patent and antitrust lawsuit concerning the drug AndroGel 1%. They sought a writ of mandamus after a district judge ruled that the application of the crime-fraud exception to the attorney-client privilege justified an order compelling the production of certain documents. The Petitioners claimed those documents were privileged.The Court of Appeals for the Third Circuit denied their petition. The court reasoned that the petitioners failed to meet the high standard for granting a petition for writ of mandamus. Specifically, they failed to show a clear and indisputable abuse of discretion or error of law, a lack of an alternate avenue for adequate relief, and a likelihood of irreparable injury.The court also found that the district court did not err in its interpretation of the crime-fraud exception to the attorney-client privilege as it applies to sham litigation. The court held that sham litigation, which involves a client’s intentional “misuse” of the legal process for an “improper purpose,” can trigger the crime-fraud exception. The court also rejected the argument that a "reliance" requirement must be applied in this context. View "In re: Abbott Laboratories" on Justia Law

by
In this case before the United States Court of Appeals for the Second Circuit, the plaintiffs were U.S. investors who purchased Mexican government bonds. They alleged that the defendants, Mexican branches of several multinational banks, conspired to fix the prices of the bonds. The defendants sold the bonds to the plaintiffs through non-party broker-dealers. The defendants moved to dismiss the case for lack of personal jurisdiction, and the District Court granted the motion, concluding that it lacked jurisdiction as the alleged misconduct, price-fixing of bonds, occurred solely in Mexico.Upon appeal, the Second Circuit vacated and remanded the case. The court found that the defendants had sufficient minimum contacts with New York as they had solicited and executed bond sales through their agents, the broker-dealers. The plaintiffs' claims arose from or were related to these contacts. The court rejected the defendants' argument that the alleged wrongdoing must occur in the jurisdiction for personal jurisdiction to exist, stating that the defendants' alleged active sales of price-fixed bonds through their agents in New York sufficed to establish personal jurisdiction. The court remanded the case for further proceedings consistent with its opinion. View "In re: Mexican Government Bonds Antitrust Litigation" on Justia Law

by
A group of 18 pension and retirement funds and other investors alleged that 10 large banks conspired to rig U.S. Treasury auctions and boycott the emergence of direct, "all-to-all" trading between buy-side investors on the secondary market for Treasuries. The alleged conspiracies violated Section 1 of the Sherman Act. The investors failed to demonstrate that the banks formed an anticompetitive agreement, which is necessary to plead their antitrust claims. The allegations of wrongful information-sharing amounted to inconsequential market chatter and their statistical analyses were not sufficiently focused on the defendant banks. The United States Court of Appeals for the Second Circuit affirmed the district court's dismissal of the lawsuit, agreeing that the investors failed to plausibly allege that the banks engaged in a conspiracy to rig Treasury auctions or to conduct a boycott on the secondary market. View "In re Treasury Securities Auction Antitrust Litigation" on Justia Law

by
In this case, three chiropractors and their respective business entities sued Wellmark, Iowa’s largest health insurer and claims administrator, alleging that the company violated Iowa antitrust laws through its Administrative Service Agreements with over 400 Iowa employers who self-fund healthcare benefits for their employees. The chiropractors argued that without these agreements, the self-funded employers would compete independently for chiropractic services, resulting in higher profits for chiropractors. The chiropractors filed a motion to certify a class of approximately 1,300 Iowa chiropractors. However, the Supreme Court of Iowa affirmed the district court's decision to deny class certification, concluding that the chiropractors failed to meet the predominance requirement for class certification as they could not prove the threshold issue of antitrust injury on a classwide basis. The court found that proving whether individual chiropractors would be better or worse off without Wellmark’s agreements would require numerous mini-trials, and thus, individual questions predominated over common questions. Additionally, the court applied the doctrine of judicial estoppel to prevent the chiropractors from belatedly reviving a different liability theory that they had previously abandoned to avoid a motion to dismiss. View "Chicoine v. Wellmark, Inc." on Justia Law

by
In the case before the Supreme Court of the State of Illinois, the State of Illinois, represented by the Attorney General, alleged that Elite Staffing, Inc., Metro Staff, Inc., and Midway Staffing, Inc. (collectively, the staffing agencies) violated the Illinois Antitrust Act. The agencies, which supplied temporary workers to a company called Colony Display, were claimed to have agreed to fix wages for their employees at below-market rates and agreed not to hire each other's employees. The staffing agencies argued that the Act did not apply to the charged conduct, and the case was sent to the Supreme Court for interlocutory review.The Supreme Court held that the Illinois Antitrust Act does not exempt agreements between competitors to hold down wages and to limit employment opportunities for their employees from antitrust scrutiny. For the purposes of the Act, the court clarified that "service" does not exclude all agreements concerning labor services. It particularly noted that multiemployer agreements concerning wages they will pay their employees and whether they will hire each other's employees may violate the Act unless the agreement arises as part of the bargaining process and the affected employees, through their collective bargaining representatives, have sought to bargain with the multiemployer unit.The court vacated the appellate court’s answer to a question it had formulated and remanded the case for further proceedings. View "State ex rel. Raoul v. Elite Staffing, Inc." on Justia Law

by
In a dispute between Ultra Bond, Inc., and its owner, Richard Campfield (collectively "Ultra Bond"), and Safelite Group, Inc. and its affiliates (collectively "Safelite"), both parties operate in the vehicle glass repair and replacement industry. Ultra Bond alleges that Safelite violated the Lanham Act by falsely advertising that windshield cracks longer than six inches could not be safely repaired and instead required replacement of the entire windshield. Safelite counterclaims that Ultra Bond stole trade secrets from Safelite in violation of state and federal law.The United States Court of Appeals for the Sixth Circuit ruled that the district court was incorrect to grant summary judgment to Safelite on Ultra Bond’s Lanham Act claim. The court held that there was sufficient evidence to suggest that Safelite's allegedly false statements may have caused economic injury to Ultra Bond, and this issue should go to a jury.The court also affirmed the district court's decision that Safelite's claims for conversion, civil conspiracy, and tortious interference with contract were preempted by the Ohio Uniform Trade Secrets Act (OUTSA). However, the court reversed the district court's grant of summary judgment to Ultra Bond on Safelite’s claim under OUTSA, ruling that Safelite's claim was not time-barred and should be evaluated further in the lower court.Finally, the court affirmed the district court's grant of summary judgment to Ultra Bond on Safelite's unfair competition claim, finding that Safelite hadn't provided enough evidence to support its claim that Ultra Bond's statements were false or that they had led to a diversion of customers from Safelite to Ultra Bond. The case was remanded for further proceedings. View "Campfield v. Safelite Group, Inc." on Justia Law

by
The United States Court of Appeals for the Eighth Circuit ruled in a case brought by the State of Missouri against several Chinese entities, including the government of the People's Republic of China, the Wuhan Institute of Virology, and others. Missouri accused the defendants of negligence in relation to the COVID-19 pandemic, alleging that they allowed the virus to spread worldwide, engaged in a campaign to keep other countries from learning about the virus, and hoarded personal protective equipment (PPE). The court decided that most of Missouri's claims were blocked by the Foreign Sovereign Immunities Act, which generally protects foreign states from lawsuits in U.S. courts. However, the court allowed one claim to proceed: the allegation that China hoarded PPE while the rest of the world was unaware of the extent of the virus. The court held that this claim fell under the "commercial activity" exception of the Foreign Sovereign Immunities Act, as it involved alleged anti-competitive behavior that had a direct effect in the United States. The case was remanded for further proceedings on this claim. View "The State of Missouri v. The Peoples Republic of China" on Justia Law

by
The case involved a dispute between Winn-Dixie Stores and the Eastern Mushroom Marketing Cooperative, Inc. (EMMC), its individual mushroom farmer members, and certain downstream distributors. Winn-Dixie accused the defendants of violating antitrust laws by engaging in a price-fixing agreement. The U.S. Court of Appeals for the Third Circuit held that the District Court was correct in applying the rule of reason, rather than a "quick-look" review, in assessing the legality of the defendants' pricing policy under the Sherman Act. The court found that the complex and variable nature of the arrangements within the cooperative, involving both horizontal and vertical components, necessitated a careful analysis to determine anticompetitive effects. The court also held that the jury's verdict, which found that the defendants' pricing policy did not harm competition, was not against the weight of the evidence and did not warrant a new trial. The court affirmed the District Court’s judgment in favor of the defendants. View "Winn Dixie Stores v. Eastern Mushroom Marketing Cooperative Inc" on Justia Law